Topics Covered
Explore Related Resources
Dr. Cotter explores emerging technologies that may enhance the evaluation, risk stratification, and monitoring of melanoma and atypical melanocytic lesions. He reviews tools ranging from
Dr. Cotter explains how utilizing clinical trial data can help clinicians overcome therapeutic inertia regarding the use of JAK inhibitors for patients with atopic dermatitis
Kara Gooding, PA-C, shares valuable insights on decoding benign versus malignant pink bumps based on a presentation at DEF Essential Resource Meeting 2026 (DERM2026) NP/PA
Dr. Blauvelt highlights the clinical significance of aiming for 100% skin clearance in patients with psoriasis based on a presentation at DEF Essential Resource Meeting
Kara Gooding, PA-C, shares valuable insights on how speaking up, negotiating, and taking strategic risks can shape a successful medical career based on a presentation